{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:41:03Z","timestamp":1791189663463,"version":"4.1.0"},"reference-count":42,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Public Health Rep"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective.<\/jats:title>\n                    <jats:p>We used a recent source of nationally representative population data on tuberculosis (TB) infection to characterize concordance between the tuberculin skin test (TST) and the QuantiFERON\u00ae-TB Gold In-Tube (QFT-GIT) blood test for immigrants in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We used TB screening data from the 2011\u20132012 National Health and Nutrition Examination Survey to examine concordance between the TST and QFT-GIT\u2014an interferon-gamma release assay (IGRA) blood test\u2014for 7,097 U.S. natives, naturalized citizens, and noncitizens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Consistent with prior findings, one in five immigrants in the survey was identified with latent TB infection (LTBI), a rate 14 times higher than for U.S. natives. We also found higher rates of discordant TST\/IGRA results among immigrants than among U.S. natives. Unadjusted discordance between TST and IGRA was 3% among U.S. natives (weighted N=5,684,274 of 191,179,213) but ranged up to 19% for noncitizens (weighted N=3,722,960 of 19,377,147). Adjusting for age, sex, and race\/ethnicity, noncitizens had more than nine times the odds of having a positive TST result but negative QFT-GIT result compared with U.S. natives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our findings suggest that whether and how either of these tests should be deployed is highly context sensitive. Significant discordance in test results when used among immigrants raises the possibility of missed opportunities for harm reduction in this already at-risk population. However, we found little distinction between the tests in terms of diagnostic outcome when used in a U.S. native population, suggesting little benefit to the adoption and use of the QFT-GIT test in place of TST on the basis of test performance alone for this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/003335491613100214","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T15:47:01Z","timestamp":1467215221000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":10,"title":["<i>Mycobacterium Tuberculosis<\/i>\n                    Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON\u00ae-TB Gold in-Tube Test among Immigrants to the U.S."],"prefix":"10.1177","volume":"131","author":[{"given":"Fernando A.","family":"Wilson","sequence":"first","affiliation":[{"name":"University of Nebraska Medical Center, Department of Health Services Research and Administration, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaddeus L.","family":"Miller","sequence":"additional","affiliation":[{"name":"University of North Texas Health Science Center, Department of Health Management and Policy, Fort Worth, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim P.","family":"Stimpson","sequence":"additional","affiliation":[{"name":"City University of New York, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"bibr1-003335491613100214","volume-title":"Reported tuberculosis in the United States","author":"Centers for Disease Control and Prevention (US)","year":"2012"},{"issue":"11","key":"bibr2-003335491613100214","first-page":"333","volume":"60","author":"Pratt R","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr3-003335491613100214","volume-title":"Global tuberculosis report 2013","author":"World Health Organization","year":"2013"},{"key":"bibr4-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-11-9"},{"key":"bibr5-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005080"},{"key":"bibr6-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2009.09.004"},{"key":"bibr7-003335491613100214","unstructured":"Centers for Disease Control and Prevention (US). Core curriculum on tuberculosis: What the clinician should know [cited 2015 Feb 16]. Available from: http:\/\/www.cdc.gov\/TB\/education\/corecurr\/index.htm."},{"key":"bibr8-003335491613100214","unstructured":"Centers for Disease Control and Prevention (US). CDC immigration requirements: Technical instructions for tuberculosis screening and treatment. Using cultures and directly observed therapy. 2009 [cited 2015 Feb 16]. Available from: http:\/\/www.cdc.gov\/immigrantrefugeehealth\/pdf\/tuberculosis-ti-2009.pdf."},{"key":"bibr9-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809497"},{"key":"bibr10-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.26.5.1258"},{"key":"bibr11-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa043194"},{"key":"bibr12-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1086\/523732"},{"key":"bibr13-003335491613100214","unstructured":"Centers for Disease Control and Prevention (US). TB elimination interferon-gamma release assays (IGRAs)\u2014blood tests for TB infection [cited 2015 Feb 16]. Available from: http:\/\/www.cdc.gov\/tb\/publications\/factsheets\/testing\/igra.pdf."},{"key":"bibr14-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-47"},{"key":"bibr15-003335491613100214","unstructured":"World Health Organization. Tuberculosis IGRA TB tests policy statement 2011 [cited 2015 Feb 16]. Available from: http:\/\/www.who.int\/tb\/features_archive\/igra_factsheet_oct2011.pdf."},{"key":"bibr16-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059546"},{"key":"bibr17-003335491613100214","first-page":"471","volume":"14","author":"Deuffic-Burban S","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"05","key":"bibr18-003335491613100214","first-page":"1","volume":"59","author":"Mazurek GH","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"bibr19-003335491613100214","first-page":"369","volume":"32","author":"Saracino A","year":"2009","journal-title":"New Microbiol"},{"key":"bibr20-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082727"},{"key":"bibr21-003335491613100214","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0650"},{"key":"bibr22-003335491613100214","unstructured":"National Center for Health Statistics (US). 2011\u20132012 National Health and Nutrition Examination Survey data [cited 2015 Feb 16]. Available from: http:\/\/wwwn.cdc.gov\/nchs\/nhanes\/search\/nhanes11_12.aspx."},{"key":"bibr23-003335491613100214","unstructured":"Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National Health and Nutrition Examination Survey: sample design, 2011\u20132014. Vital Health Stat 2(162) 2014."},{"key":"bibr24-003335491613100214","unstructured":"Centers for Disease Control and Prevention (US). Tuberculosis: Testing and diagnosis [cited 2015 Feb 16]. Available from: http:\/\/www.cdc.gov\/TB\/topic\/testing\/default.htm."},{"key":"bibr25-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68579-6"},{"key":"bibr26-003335491613100214","unstructured":"QuantiFERON. QuantiFERON\u00ae-TB Gold (QFT\u00ae) ELISA package insert [cited 2015 Nov 23]. Available from: http:\/\/www.quantiferon.com\/irm\/content\/PI\/QFT\/2PK\/UK.pdf."},{"key":"bibr27-003335491613100214","volume-title":"Stata\u00ae: Release 13","author":"StataCorp","year":"2013"},{"key":"bibr28-003335491613100214","first-page":"610","volume-title":"Health Information for International Travel 2014","author":"Walker PF","year":"2014"},{"key":"bibr29-003335491613100214","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201308-1480OC","volume":"189","author":"Walter ND","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"bibr30-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.1.32"},{"key":"bibr31-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2949"},{"key":"bibr32-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-10-259"},{"key":"bibr33-003335491613100214","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00006"},{"key":"bibr34-003335491613100214","volume-title":"American Community Survey Reports","author":"Grieco EM","year":"2012"},{"key":"bibr35-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1200894"},{"issue":"6","key":"bibr36-003335491613100214","first-page":"1","volume":"49","author":"Targeted tuberculin testing and treatment of latent tuberculosis infection","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"15","key":"bibr37-003335491613100214","first-page":"1","volume":"54","author":"Guidelines for the investigation of contacts of persons with infectious tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr38-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507273330404"},{"key":"bibr39-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1016\/0277-9536(85)90269-2"},{"key":"bibr40-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(00)00170-2"},{"key":"bibr41-003335491613100214","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199905000-00003"},{"key":"bibr42-003335491613100214","first-page":"e17405","volume":"6","author":"Ricks PM","year":"2012","journal-title":"PLoS One"}],"container-title":["Public Health Reports\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/003335491613100214","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/003335491613100214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:32:45Z","timestamp":1777627965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/003335491613100214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1177\/003335491613100214"],"URL":"https:\/\/doi.org\/10.1177\/003335491613100214","relation":{},"ISSN":["0033-3549","1468-2877"],"issn-type":[{"value":"0033-3549","type":"print"},{"value":"1468-2877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}